4Friedman AN, Hunsicker LG, Selhub J, et al. Proteinuria as a predictor of total plasma bomocystein levels in type 2 diabetic nephropathy[J]. Diabetes Care, 2002,25(11): 2037-2041.
5Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [J]. Diabetes, 2001,50 (10) : 2384-2389.
6Lateiza F, Price P, Scolt G, et al. Cystatin C: and improved estimator of glomerular filtration rate[J]. J Clin Chem, 2003,52 : 699-707.
7Kerkeni M, Hyperhomocystenemia. Paoxonaseconcentration and cardiovascuIar complications in Tunisian patients with nondiabeticrenal disease[J].Oifn Biochem,2009,2(9):6-12.
8Jalanko H ,Patrakka J ,Tryggvason K.Holmberg C:Genetic kidney dislose the pathogenesis of urine[J]. Ann Med ,200] ,53:526-535.
9Becker A, Henry M, Kostense PJ, et el. Plasma homocysteine end s-edenosylmethionine in erythrocytes as determinants of carotid intima- media hicknes$: different effects in diabetic end non-diabetic individuals,]. Atherosclerosis, 2003, 169(2), 323--350.
